| Authors: |
Kailavasan M; Department of Urology, Victoria Hospital, London, Ontario, Canada. Electronic address: mithunk@hotmail.co.uk., Martini A; Department of Urology, University of Cincinnati, Cincinnati, OH, USA., Bruins M; Department of Urology, Zuyderland Medisch Centrum, Sittard/Heerlen, The Netherlands., Carrion A; Department of Urology, Vall Hebron Hospital, Autonomous University of Barcelona, Barcelona, Spain., Cathomas R; Department of Medical Oncology, Kantonsspital Graubünden, Chur, Switzerland., Compérat E; Department of Pathology, Medical University Vienna, General Hospital, Vienna, Austria., Efstathiou JA; Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA, USA., Fietkau R; Department of Radiation Therapy, University of Erlangen, Erlangen, Germany., Lorch A; Department of Medical Oncology and Hematology, University Hospital Zürich, Zürich, Switzerland., Mertens LS; Department of Urology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Meijer RP; Department of Oncological Urology, University Medical Center Utrecht, Utrecht, The Netherlands., Mariappan P; Edinburgh Bladder Cancer Surgery (EBCS), Western General Hospital, University of Edinburgh, Edinburgh, UK., Milowsky MI; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA., Neuzillet Y; Department of Urology, Foch Hospital, University of Versailles-Saint-Quentin-en-Yvelines, Suresnes, France., Panebianco V; Department of Radiological Sciences, Oncology and Pathology, Sapienza University of Rome, Rome, Italy., Rink M; Department of Urology, Marienkrankenhaus Hamburg, Hamburg, Germany., Thalmann GN; Department of Urology, Inselspital, University Hospital Bern, Bern, Switzerland., Sæbjørnsen S; Patient Representative, European Association of Urology Guidelines Office, Arnhem, The Netherlands., van der Heijden AG; Department of Urology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands. |
